Astrotech Corporation (DE) Common Stock vs. Bio-Rad Laboratories, Inc.Class A
ASTC
Astrotech Corporation (DE) Common Stock
$9.01 -1.10%
VS BIOBio-Rad Laboratories, Inc.Class A
$342.43 -1.56%
Bio-Rad Laboratories, Inc.Class A (BIO) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| ASTC | BIO | |
|---|---|---|
| Market Cap | $18.10 million | $9.16 billion |
| Revenue (TTM) | $959,000 | $2.59 billion |
| Net Income (TTM) | $-14,091,000 | $222.40 million |
BIO leads on 3 of 3 size & scale factors.
Valuation
| ASTC | BIO | |
|---|---|---|
| P/E Ratio | — | 41.71 |
| Price / Book | 1.49 | 1.28 |
| Price / Sales | 18.88 | 3.54 |
BIO leads on 2 of 2 valuation factors.
Profitability
| ASTC | BIO | |
|---|---|---|
| Net Margin | -1469.34% | 8.59% |
| Return on Equity | -115.93% | 3.10% |
BIO leads on 2 of 2 profitability factors.
Risk & Sentiment
| ASTC | BIO | |
|---|---|---|
| Short Interest | 1.71% | 2.44% |
ASTC leads on 1 of 1 risk & sentiment factors.
Dig deeper: ASTC overview, ASTC financials, BIO overview, BIO financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.